semaglutide patent expiry us 2031 weight-loss drug has expired in India, Indian pharmaceutical has wasted no-time to announce generics. What is the most pressing concern about semaglutide generics in India? ✅️Use without prescription is risky Peptide Biosimilars: What Happens When

Mistake 1: Storing in the refrigerator door The refrigerator door is the worst location for temperature-sensitive medications

This is what makes a once-daily oral GLP-1 treatment viable at a dose proven to support meaningful weight loss

This study demonstrates how database studies rooted in benchmarks against previously conducted randomized trials for the drugs of interest can produce complementary evidence to support expanded cardiovascular indications

This reduces confidence in the treatment and slows adoption

Since that

The phase 2 study to evaluate the efficacy, safety and tolerability of maridebart cafraglutide is currently ongoing (ClinicalTrials.gov number, NCT05669599)